CPA
MRK icon

Capital Performance Advisors’s Merck MRK Stock Holding History

Capital Performance Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Sell
3,294
-8,562
-72% -$1M 0.03% 187
2026
Q1 		$1.43M Buy
11,856
+670
+6% +$77.4K 0.1% 93
2025
Q4 		$1.18M Buy
11,186
+2,534
+29% +$238K 0.08% 103
2025
Q3 		$726K Buy
8,652
+212
+3% +$17.5K 0.12% 91
2025
Q2 		$668K Buy
8,440
+5,613
+199% +$446K 0.13% 82
2025
Q1 		$254K Buy
+2,827
New +$264K 0.06% 193
2024
Q4 		– Sell
-738
Closed -$83.9K – 1704
2024
Q3 		$83.9K Buy
+738
New +$87.7K 0.03% 234

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Performance Advisors's MRK Position: Q2 2026 in Review

Capital Performance Advisors reduced its Merck (MRK) stake by 72% in Q2 2026, selling an estimated $1M and leaving 3,294 shares worth $423K. The position accounts for 0.03% of the portfolio, ranked #187.

Capital Performance Advisors first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.43M in Q1 2026. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Performance Advisors held 3,294 shares of Merck worth $423K as of Q2 2026.
  • Capital Performance Advisors sold 8,562 Merck shares in Q2 2026, an estimated $1M.
  • Merck made up 0.03% of Capital Performance Advisors's portfolio in Q2 2026, its #187 holding.
  • Capital Performance Advisors first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • Capital Performance Advisors's Merck position peaked at $1.43M in Q1 2026.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.